SCHEMBL21114474

SCHEMBL21114474

CC#CC(O)O.OCC#CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL27969398 0.82
SCHEMBL148912 0.82
SCHEMBL29165411 0.78
SCHEMBL30495494 0.78
SCHEMBL30423196 0.78
Hydrochloric Acid SCHEMBL29099790 0.78
Propanol SCHEMBL31488643 0.78 LMNA (0.32)
1,4-Butanediol SCHEMBL27324072 0.78 SMN1; SMN2 (0.36)
Glycerin SCHEMBL27679416 0.78 LMNA (0.50)
Methoxymethane SCHEMBL11545279 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190214145-A1 Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen KUREK ITZHAK (US) 2019-07-11 US disclosed